{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:44:13Z","timestamp":1790214253797,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271287"],"award-info":[{"award-number":["81271287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejphar.2018.10.019","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T12:22:06Z","timestamp":1539606126000},"page":"50-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The neuroprotective effect of lithium chloride on cognitive impairment through glycogen synthase kinase-3\u03b2 inhibition in intracerebral hemorrhage rats"],"prefix":"10.1016","volume":"840","author":[{"given":"Zhen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.10.019_bib1","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1523\/JNEUROSCI.2155-07.2007","article-title":"NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus","volume":"27","author":"Al-Hallaq","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.10.019_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2018.10.019_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/02688697.2013.815314","article-title":"Cognitive performance following spontaneous subarachnoid haemorrhage versus other forms of intracranial haemorrhage","volume":"28","author":"Brand","year":"2014","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.ejphar.2018.10.019_bib4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-4159.2006.03969.x","article-title":"Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit","volume":"98","author":"Bretin","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2018.10.019_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4161\/chan.18919","article-title":"Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model","volume":"6","author":"Brittain","year":"2012","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.ejphar.2018.10.019_bib6","doi-asserted-by":"crossref","first-page":"2701526","DOI":"10.1155\/2016\/2701526","article-title":"Role of NMDA receptor-mediated glutamatergic signaling in chronic and acute neuropathologies","volume":"2016","author":"Carvajal","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2018.10.019_bib7","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/MCB.20.8.2687-2695.2000","article-title":"The Rel\/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)","volume":"20","author":"Chen","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2018.10.019_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2010.07.006","article-title":"Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders","volume":"128","author":"Chiu","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2018.10.019_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/156720205774962683","article-title":"Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity","volume":"2","author":"Chong","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.ejphar.2018.10.019_bib10","first-page":"263","article-title":"The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappab to foster endogenous microglial cell protection","volume":"19","author":"Chong","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2018.10.019_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnmol.2011.00015","article-title":"GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke","volume":"4","author":"Chuang","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2018.10.019_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mc.10169","article-title":"Crossregulation of NF-kappaB by the APC\/GSK-3beta\/beta-catenin pathway","volume":"39","author":"Deng","year":"2004","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejphar.2018.10.019_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2018.10.019_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2012.00014","article-title":"Inhibition of GSK3 by lithium, from single molecules to signaling networks","volume":"5","author":"Freland","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2018.10.019_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(91)90889-2","article-title":"Excitotoxic index--a biochemical marker of selective vulnerability","volume":"127","author":"Globus","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.10.019_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11910-015-0545-1","article-title":"Glutamate and GABA imbalance following traumatic brain injury","volume":"15","author":"Guerriero","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ejphar.2018.10.019_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12035-011-8166-4","article-title":"Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications","volume":"43","author":"Hensley","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.10.019_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/fnl.12.68","article-title":"Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders","volume":"7","author":"Khanna","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.ejphar.2018.10.019_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2013.07.010","article-title":"Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments","volume":"141","author":"King","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2018.10.019_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2018.10.019_bib21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1179\/1743132815Y.0000000067","article-title":"Experimental intracerebral haemorrhage: description of a semi-coagulated autologous blood model in rats","volume":"37","author":"Liu","year":"2015","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejphar.2018.10.019_bib22","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.1523\/JNEUROSCI.2929-06.2006","article-title":"The activation of excitatory glutamate receptors evokes a long-lasting increase in the release of GABA from cerebellar stellate cells","volume":"26","author":"Liu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.10.019_bib23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00726-015-1925-1","article-title":"Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC","volume":"47","author":"Perucho","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2018.10.019_bib24","doi-asserted-by":"crossref","first-page":"e0178886","DOI":"10.1371\/journal.pone.0178886","article-title":"High prevalence of cognitive impairment after intracerebral hemorrhage","volume":"12","author":"Planton","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.10.019_bib25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2018.10.019_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/1570159X14666151230110058","article-title":"Molecular, cellular and clinical aspects of intracerebral hemorrhage: are the enemies within?","volume":"14","author":"Righy","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2018.10.019_bib27","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.47.4_Suppl_2.19S","article-title":"Excitotoxicity hypothesis","volume":"47","author":"Rothstein","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2018.10.019_bib28","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1089\/neu.2015.4177","article-title":"Inhibition of glycogen synthase kinase-3: an emerging target in the treatment of traumatic brain injury","volume":"33","author":"Shim","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2018.10.019_bib29","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1128\/MCB.25.19.8444-8455.2005","article-title":"Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription","volume":"25","author":"Steinbrecher","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2018.10.019_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1037\/bne0000078","article-title":"Using the spatial learning index to evaluate performance on the water maze","volume":"129","author":"Tomas Pereira","year":"2015","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2018.10.019_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2018.10.019_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3171\/2016.7.JNS1668","article-title":"Activation of peroxisome proliferator-activated receptor-gamma by a 12\/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage","volume":"127","author":"Xu","year":"2017","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejphar.2018.10.019_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cell.2004.11.012","article-title":"GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity","volume":"120","author":"Yoshimura","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2018.10.019_bib34","article-title":"Brain-specific Crmp2 deletion leads to neuronal development deficits and behavioural impairments in mice","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2018.10.019_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1179\/1743132812Y.0000000025","article-title":"Activation of Akt\/GSK-3beta\/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats","volume":"34","author":"Zhao","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejphar.2018.10.019_bib36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3171\/2016.7.JNS152995","article-title":"Lithium posttreatment confers neuroprotection through glycogen synthase kinase-3beta inhibition in intracerebral hemorrhage rats","volume":"127","author":"Zheng","year":"2017","journal-title":"J. Neurosurg."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918305958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918305958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T21:11:29Z","timestamp":1540933889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918305958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"alternative-id":["S0014299918305958"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.10.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuroprotective effect of lithium chloride on cognitive impairment through glycogen synthase kinase-3\u03b2 inhibition in intracerebral hemorrhage rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}